Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Juvenile Scleroderma-What has Changed in the Meantime?

Current rheumatology reviews - 1 Jan 2018

Adrovic Amra, Sahin Sezgin, Barut Kenan, Kasapcopur Ozgur

Abstract excerpt

BACKGROUND: Juvenile scleroderma is a rarely seen chronic connective tissue disorder characterized by stiffening of the skin. The frequency of the disease was reported as one per million. According to organ involvement, the disease is divided into two main forms: systemic and localized scleroderma. OBJECTIVE: Since it is uncommon in children, many aspects of the disease remain discussable. With this review, we...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Skin
Share to Age of Onset
Share to Genetic Predisposition to Disease

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Phenotype

Share to Prognosis

Share to Scleroderma, Systemic

Share to Severity of Illness Index

Source

Identifiers

PMID: 29692255
DOI: 10.2174/1573397114666180423105056

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Juvenile Scleroderma-What has Changed in the Meantime?PMID 29692255Read ↗

Juvenile and adult-onset scleroderma: Different clinical phenotypes.Semantic proximity Read ↗

Juvenile localized scleroderma: clinical and epidemiological features in 750 children. An international study.Semantic proximity Read ↗

Paediatric rheumatic disease: Phenotype and prognosis of juvenile systemic lupus erythematosus.Semantic proximity Read ↗

Effect of the Janus kinase inhibitor tofacitinib in the treatment of juvenile scleroderma: A single‐center experienceSemantic proximity Read ↗

The conundrum of juvenile spondyloarthritis classification: Many names for a single disease? Lesson learned from an instructive clinical case.Semantic proximity Read ↗

The Significance of Autoantibodies in Juvenile Dermatomyositis.Semantic proximity Read ↗

Diagnosis and classification of juvenile idiopathic arthritis.Semantic proximity Read ↗

Polyarticular juvenile idiopathic arthritis – epidemiology and management approachesSemantic proximity Read ↗

Phenotypic characteristics and outcome of juvenile dermatomyositis in Arab children.Semantic proximity Read ↗

Juvenile Idiopathic Arthritis in Harlequin Ichthyosis, a Rare Combination or the Clinical Spectrum of the Disease? Report of a Child Treated With Etanercept and Review of the Literature Semantic proximity Read ↗

Immunopathogenesis of Juvenile Systemic SclerosisSemantic proximity Read ↗

Relapsing polychondritis: a chameleon among orphan diseases.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.